Restenosis rate, acute and net gain, and late loss of 79 in-stent restenoses
| Restenosis rate follow up in terms of strategy of TLR (%) | |
| ELCA | 78 (22) |
| PTCA | 48 (18) |
| Stent | 47 (19) |
| Acute gain in terms of strategy of TLR (mm) | |
| ELCA | 1.3 (0.3) |
| PTCA | 1.1 (0.2) |
| Stent | 1.4 (0.4) |
| Late loss in terms of strategy of TLR (mm) | |
| ELCA | 0.95 (0.4) |
| PTCA | 0.60 (0.3) |
| Stent | 0.93 (0.4) |
| Net gain (mm) | 0.02 (0.01) |
| Net gain follow up (mm) | 0.45 (0.60) |
| Net gain in terms of strategy of follow up (mm) | |
| ELCA | 0.3 (0.2) |
| PTCA | 0.5 (0.3) |
| Stent | 0.5 (0.2) |
Values are mean (SD).